ChemicalBook
English   Japanese   Germany   Korea

L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl-

, 245124-26-9, 结构式
CAS号:
245124-26-9
英文名:
L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl-
英文别名:
L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl-
中文名:
中文别名:
CBNumber:
CB28381244
分子式:
C86H129N15O24
分子量:
1757.03
MOL File:
245124-26-9.mol

L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl-化学性质

沸点:
1919.8±65.0 °C(Predicted)
密度:
1.270±0.06 g/cm3(Predicted)
酸度系数(pKa):
3.23±0.10(Predicted)
安全信息

L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl-性质、用途与生产工艺

生物活性

GAD65 (206-220) 来源于谷氨酸脱羧酶 (GAD) 65 蛋白的 180-188 残基。GAD65 与 I-Ag7 的 MHC II 类分子结合呈递给 T 细胞,也是在 I 型糖尿病中被自身反应性 T 细胞靶向的主要胰腺抗原。

L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl- 上下游产品信息

上游原料

下游产品


L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl- 生产厂家

供应商联系电话电子邮件国家产品数优势度
MedChemExpress sales@medchemexpress.com 美国 6398 58
 

245124-26-9, L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl- 相关搜索:

  • C86H129N15O24
  • 245124-26-9
  • L-Threonine, L-threonyl-L-tyrosyl-L-α-glutamyl-L-isoleucyl-L-alanyl-L-prolyl-L-valyl-L-phenylalanyl-L-valyl-L-leucyl-L-leucyl-L-α-glutamyl-L-tyrosyl-L-valyl-
Copyright 2016 © ChemicalBook. All rights reserved